Literature DB >> 17211013

The prevention of cardiovascular disease: have we really made progress?

Thomas A Pearson1.   

Abstract

Despite reductions in cardiovascular disease (CVD) mortality, current evidence suggests that CVD is not being prevented but, rather, is being made less lethal. Evidence-based guidelines have been developed for secondary, primary, and community-based prevention. To improve compliance with secondary prevention guidelines, programs must better organize and monitor care. Primary prevention requires assessment of risk in asymptomatic people, to yield cost-effective benefits. CVD prevention at the societal level should target deleterious behavior in community settings, using effective public health interventions. Policy options that involve multiple preventive approaches offer the best opportunity to minimize the economic and social burdens of CVD.

Entities:  

Mesh:

Year:  2007        PMID: 17211013     DOI: 10.1377/hlthaff.26.1.49

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  6 in total

Review 1.  Stem cells: An eventual treatment option for heart diseases.

Authors:  Joseph C Bilgimol; Subbareddy Ragupathi; Lakshmanan Vengadassalapathy; Nathan S Senthil; Kalimuthu Selvakumar; M Ganesan; Sadananda Rao Manjunath
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

2.  Preventing preterm birth--is it really impossible?: a comment on the IOM report on preterm birth.

Authors:  Emile Papiernik
Journal:  Matern Child Health J       Date:  2007-06-12

3.  Health and functioning among baby boomers approaching 60.

Authors:  Linda G Martin; Vicki A Freedman; Robert F Schoeni; Patricia M Andreski
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-03-18       Impact factor: 4.077

4.  Community-wide cardiovascular disease prevention programs and health outcomes in a rural county, 1970-2010.

Authors:  N Burgess Record; Daniel K Onion; Roderick E Prior; David C Dixon; Sandra S Record; Fenwick L Fowler; Gerald R Cayer; Christopher I Amos; Thomas A Pearson
Journal:  JAMA       Date:  2015-01-13       Impact factor: 56.272

Review 5.  Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2011-06-13       Impact factor: 4.162

6.  More americans living longer with cardiovascular disease will increase costs while lowering quality of life.

Authors:  Ankur Pandya; Thomas A Gaziano; Milton C Weinstein; David Cutler
Journal:  Health Aff (Millwood)       Date:  2013-10       Impact factor: 6.301

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.